Point of Care Diagnostics for Emerging Infectious Disease Threats (Market Analysis and Technical Considerations)

17 Oct 2011 • by Natalie Aster

New YorkA salient characteristic of low resource settings in developed and developing countries is a lack of skilled and trained laboratory personnel and test operators. There is also little attention and resources given to product support and after sales service. As is often the case, technology has pushed ahead of our ability to incorporate point of care type products developed by new technologies into healthcare delivery systems.

In many developing countries, laboratory services have been neglected due to chronic under-investment. Furthermore, the high burden of infectious diseases and emergence of drug-resistant diseases such as malaria, TB and others have increased the strain on laboratories. These conditions also complicate the diagnostic process in rural settings. Many rural communities in developed countries suffer a similar underinvestment.

Report Details:

Point of Care Diagnostics for Emerging Infectious Disease Threats (Market Analysis and Technical Considerations)

Published: October 2011
Pages: 150
Price: US$ 3,500.00

Report Sample Abstract

Multinational organizations such as Medecins Sans Frontieres/Doctors Without Borders (MSF) and Drugs for Neglected Disease Initiative (DNDi) have launched programs throughout Latin America that integrate treatment and diagnosis at the primary healthcare level.

In 2009, the Member States of Pan American Health Organization (PAHO) adopted the resolution “Elimination of neglected diseases and other poverty-related infections”, where the primary strategy includes first line treatment of children and medical care for adults.

May 2010, the World Health Assembly (WHA) of the WHO adopted a resolution “Chagas Disease: Control and Elimination”. The resolution includes the integration of treatment and diagnosis at primary healthcare level for patients in both acute and chronic phases of the disease.

A MSF press release commented on the resolution: “After more than 10 years of experience, MSF has successfully treated thousands of patients with Chagas. We would like to see equal importance given to treatment and diagnosis as with prevention strategies. The countries affected must agree to integrate diagnosis and treatment at the primary health level if they want to reach all patients; children and adults, in both acute and chronic phases of the disease.”

“Besides, the resolution includes other important points like the reinforcement of the provision of existing treatments in disease-endemic countries with the aim of making access universal; and the promotion of operational research on the control of Chagas disease in order to promote the development of a valid and accessible test of cure.

However, the resolution approved by the WHA missed the opportunity to include an important point: the need to promote alternative mechanisms of financing the research and development for better rapid diagnostic tests, new treatments and a test of cure.”

Medecins Sans Frontieres/Doctors Without Borders (MSF) reported that it has screened more than XXX people for Chagas and has treated over XXX patients with the disease since 1999. In Honduras, MSF opened its first Chagas project in 1999. Since then, the medical organisation has developed several programmes in Nicaragua, Guatemala. Currently, MSF screens, diagnoses and treats children and adults in Bolivia and Colombia and is now starting a new project in Paraguay.

More information can be found in the report “Point of Care Diagnostics for Emerging Infectious Disease Threats (Market Analysis and Technical Considerations)” by Kalorama Information.

To order the report or ask for sample pages contact ps@marketpublishers.com


MarketPublishers, Ltd.

Tanya Rezler

Tel: +44 208 144 6009

Fax: +44 207 900 3970